Kane Biotech Inc. (KNBIF)
OTCMKTS
· Delayed Price · Currency is USD
0.0332
-0.0018 (-5.14%)
Jul 15, 2025, 9:45 AM EDT
Kane Biotech Revenue
Kane Biotech had revenue of 412.51K CAD in the quarter ending March 31, 2025, with 695.04% growth. This brings the company's revenue in the last twelve months to 2.44M, up 1,374.38% year-over-year. In the year 2024, Kane Biotech had annual revenue of 2.08M with 1,296.75% growth.
Revenue (ttm)
2.44M CAD
Revenue Growth
+1,374.38%
P/S Ratio
2.85
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.85M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.08M | 1.93M | 1,296.75% |
Dec 31, 2023 | 148.98K | -7.75K | -4.95% |
Dec 31, 2022 | 156.73K | -1.45M | -90.25% |
Dec 31, 2021 | 1.61M | 266.20K | 19.84% |
Dec 31, 2020 | 1.34M | -351.95K | -20.78% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Kane Biotech News
- 22 hours ago - Kane Biotech to Present at Advanced Wound Care Summit USA - GlobeNewsWire
- 18 days ago - Philip Renaud files Early Warning Report in respect of Kane Biotech Inc. - Benzinga
- 18 days ago - Kane Biotech Announces Conversion of Demand Loan from Insider into an Unsecured Convertible Debenture and Annual General Meeting Voting Results - GlobeNewsWire
- 26 days ago - Kane Biotech Provides Further Corporate Update - GlobeNewsWire
- 6 weeks ago - Kane Biotech reports Q1 results - Seeking Alpha
- 6 weeks ago - Kane Biotech Announces First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Philip Renaud files Early Warning Report in respect of Kane Biotech Inc. - Benzinga
- 2 months ago - Kane Biotech Announces Closing of Private Placement Offering and Loan with Insiders of the Company - GlobeNewsWire